PHVS · Pharvaris N.V. · Metrics
Market Cap
$2.25B
Shares
70.20M
Volume · Oct 5
816.23K
Avg daily vol (3M)
744.19K
PHVS metrics
42 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$30.49
Market cap
$2.25B
Price action
20 metricsPrice change (1W)
-2.6%
Price change (30D)
-17.6%
Price change (3M)
-7.9%
Price change (6M)
+9.2%
Price change (YTD)
+12.4%
Price change (1Y)
+34.6%
Trailing year
Price change (5Y)
+75.7%
52-week high
$38.86
52-week low
$20.96
Change from 52-week high
-19.7%
Change from 52-week low
+48.8%
Annualized volatility
54.7%
Annualized volatility (3M)
43.8%
Beta
0.9
RSI (14D)
30.2
Price vs SMA 50
-11.0%
Price vs SMA 200
+2.4%
Avg volume (3M)
743,069
Relative volume
0.8
Average dollar volume
$26.54M
Company
3 metricsSector
Healthcare
Industry
Biotechnology
Shares outstanding
70.20M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
7.1
reciprocal yield 14.2%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-2.5%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
−$56.57M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+19.9%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-26.3%
Return on assets
-24.3%
Debt / equity
—
Current ratio
—
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$342.31M
Total assets
$353.79M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
125
13F filer change QoQ
+14
Institutional ownership
92.0%
Short interest
3 metricsShort interest
2.5%
Latest settlement · 1.2 days to cover
Days to cover
1.2d
Short-squeeze score
38 / 100
Insider activity
2 metricsNet insider buying (90D)
−$20.50M
Insider-sentiment score
5 / 100
Risk flags
1 metricsGoing concern
—